Author: <span>Mesothelioma News</span>

Scottish medicines consortium accepts the use of Alimta (pemetrexed)…

On 8th December 2014, the Scottish Medicines Consortium accepted for use within NHS Scotland Alimta monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer in patients whose disease has not progressed imme…

Polaris Group Announces Treatment of First Patient in Phase 1 Study…

Polaris Group is currently conducting clinical trials on ADI-PEG 20 in combination with cisplatin in melanoma and ovarian cancer, in combination with doxorubicin in HER2 negative breast cancer, in combination with nab-paclitaxel and gemcitabine for adv…

Malignant Pleural Mesothelioma Drugs Pipeline: New analysis released

This report provides comprehensive information on the therapeutic development for Malignant Pleural Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action , route of administratio…

Council still counting cost of 2013 compensation claims already reaching over 200k

A housing officer was paid A 48,000 after contracting Mesothelioma, a form of lung cancer caused by exposure to asbestos, a Freedom of Information disclosure has revealed. A teacher was awarded A 27,000 after a similar action, with the council paying A…